Australia markets closed

OncoCyte Corporation (OCX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.7400+0.0900 (+3.40%)
At close: 04:00PM EDT
2.7800 +0.04 (+1.46%)
After hours: 04:19PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
8,097
1,503
958
2,198
1,216
-
Cost of revenue
8,749
1,090
976
778
1,855
-
Gross profit
-652
413
-18
1,420
-639
-
Operating expenses
Research development
19,714
9,294
7,301
5,035
9,800
-
Selling general and administrative
36,913
13,536
21,533
20,392
23,282
-
Total operating expenses
56,627
22,830
28,834
25,427
33,082
-
Operating income or loss
-57,279
-22,417
-28,852
-24,007
-33,721
-
Interest expense
302
52
83
209
252
-
Total other income/expenses net
-6,326
-2,386
10,323
-28,655
2,787
-
Income before tax
-63,712
-24,855
-18,612
-52,871
-31,186
-
Income tax expense
97
-
0
-9,261
-1,254
0
Income from continuing operations
-63,809
-24,855
-18,612
-43,610
-29,932
-
Net income
-63,809
-27,781
-72,902
-64,097
-29,932
-
Net income available to common shareholders
-64,103
-28,723
-73,422
-64,097
-29,932
-
Basic EPS
-9.66
-3.75
-13.25
-14.40
-9.20
-
Diluted EPS
-9.66
-3.75
-13.25
-14.40
-9.20
-
Basic average shares
7,069
7,651
5,540
4,446
3,274
-
Diluted average shares
7,069
7,651
5,540
4,446
3,274
-